Pacific Shuanglin Bio-pharmacy Co Ltd Sustainability Reports
Pacific Shuanglin Bio-pharmacy Co., Ltd. is engaged in the research, development, production, and marketing of blood products. Its product portfolio includes human albumin, intravenous immunoglobulin, and multiple specialized human immunoglobulins.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001S7M060
2 reports from 2021 to 2025
